13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Biological Functions and Clinical Applications of Integrins in Cancers

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Integrins are the adhesion molecules and receptors of extracellular matrix (ECM). They mediate the interactions between cells-cells and cells-ECM. The crosstalk between cancer cells and their microenvironment triggers a variety of critical signaling cues and promotes the malignant phenotype of cancer. As a type of transmembrane protein, integrin-mediated cell adhesion is essential in regulating various biological functions of cancer cells. Recent evidence has shown that integrins present on tumor cells or tumor-associated stromal cells are involved in ECM remodeling, and as mechanotransducers sensing changes in the biophysical properties of the ECM, which contribute to cancer metastasis, stemness and drug resistance. In this review, we outline the mechanism of integrin-mediated effects on biological changes of cancers and highlight the current status of clinical treatments by targeting integrins.

          Related collections

          Most cited references93

          • Record: found
          • Abstract: found
          • Article: not found

          Every step of the way: integrins in cancer progression and metastasis

          Cell adhesion to the extracellular matrix is fundamental to tissue integrity and human health. Integrins are the main cellular adhesion receptors that through multifaceted roles as signalling molecules, mechanotransducers and key components of the cell migration machinery are implicated in nearly every step of cancer progression from primary tumour development to metastasis. Altered integrin expression is frequently detected in tumours, where integrins have roles in supporting oncogenic growth factor receptor (GFR) signalling and GFR-dependent cancer cell migration and invasion. In addition, integrins determine colonization of metastatic sites and facilitate anchorage-independent survival of circulating tumour cells. Investigations describing integrin engagement with a growing number of versatile cell surface molecules, including channels, receptors and secreted proteins, continue to lead to the identification of novel tumour-promoting pathways. Integrin-mediated sensing, stiffening and remodelling of the tumour stroma are key steps in cancer progression supporting invasion, acquisition of cancer stem cell characteristics and drug resistance. Given the complexity of integrins and their adaptable and sometimes antagonistic roles in cancer cells and the tumour microenvironment, therapeutic targeting of these receptors has been a challenge. However, novel approaches to target integrins and antagonism of specific integrin subunits in stringently stratified patient cohorts are emerging as potential ways forward.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Integrin ligands at a glance.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Integrins as biomechanical sensors of the microenvironment

              Integrins, and integrin-mediated adhesions, have long been recognized to provide the main molecular link attaching cells to the extracellular matrix (ECM) and to serve as bidirectional hubs transmitting signals between cells and their environment. Recent evidence has shown that their combined biochemical and mechanical properties also allow integrins to sense, respond to and interact with ECM of differing properties with exquisite specificity. Here, we review this work first by providing an overview of how integrin function is regulated from both a biochemical and a mechanical perspective, affecting integrin cell-surface availability, binding properties, activation or clustering. Then, we address how this biomechanical regulation allows integrins to respond to different ECM physicochemical properties and signals, such as rigidity, composition and spatial distribution. Finally, we discuss the importance of this sensing for major cell functions by taking cell migration and cancer as examples.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                11 September 2020
                2020
                : 11
                : 579068
                Affiliations
                [1] 1 The Fifth Affiliated Hospital, Key Laboratory of Molecular Target and Clinical Pharmacology and the State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University , Guangzhou, China
                [2] 2 The First Affiliated Hospital, Hainan Medical University , Haikou, China
                [3] 3 Guangzhou Institute of Pediatrics/Guangzhou Women and Children’s Medical Center, Guangzhou Medical University , Guangzhou, China
                [4] 4 Institute of Immunology and School of Medicine, Shanxi Datong University , Datong, China
                Author notes

                Edited by: Xiaoping Lin, Sun Yat-sen University Cancer Center (SYSUCC), China

                Reviewed by: Zhi Shi, Jinan University, China; Longyang Liu, Southern Medical University, China

                *Correspondence: Jian-ye Zhang, jianyez@ 123456163.com ; Yan-yan Yan, zwsanyan@ 123456163.com ; Yun Liu, liokvie@ 123456163.com

                †These authors have contributed equally to this work

                This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

                Article
                10.3389/fphar.2020.579068
                7522798
                33041823
                8a155aab-5525-46d8-983b-7370576be976
                Copyright © 2020 Su, Li, Zhang, Wang, Wang, Tao, Wang, Guo, Li, Liu, Yan and Zhang

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 01 July 2020
                : 24 August 2020
                Page count
                Figures: 3, Tables: 3, Equations: 0, References: 119, Pages: 14, Words: 6929
                Funding
                Funded by: National Natural Science Foundation of China 10.13039/501100001809
                Award ID: 81773888 , 81902152, U1903126
                Funded by: Natural Science Foundation of Guangdong Province 10.13039/501100003453
                Award ID: 2020A151501005, 2020A1515010605
                Categories
                Pharmacology
                Review

                Pharmacology & Pharmaceutical medicine
                integrins,cancer metastasis,drug resistance,stemness,extracellular matrix,therapeutic targeting

                Comments

                Comment on this article